Related by context. Frequent words. (Click for all words.) 68 phase IIa 68 Phase Ia 66 pharmacokinetic profile 65 ISIS # 65 Phase 2a trial 65 Phase IIa clinical 64 Phase 1a 64 Phase 2a clinical 64 Phase 1b trial 64 active comparator 63 multiple ascending dose 63 JANUVIA 63 orally bioavailable 63 thymalfasin 63 teduglutide 62 eniluracil 62 tolerability profile 62 SRT# [003] 62 axitinib 62 dose escalation trial 62 TRIOLEX 62 administered subcutaneously 62 Pharmacokinetic 62 antisense drug 61 diabetic neuropathic pain 61 methylnaltrexone 61 oral bioavailability 61 pharmacokinetic studies 61 SCH # 61 Phase 1b 61 pharmacodynamic 61 LIALDA 61 ADXS# 61 tocilizumab 61 BAY #-# 61 Phase Ib 61 LY# [003] 61 MAP# 61 intravenously administered 61 antitumor activity 61 tolerability 60 6R BH4 60 decitabine 60 CYT# 60 phase 2a 60 Phenoptin 60 Elesclomol 60 Phase 1b clinical 60 efficacy 60 PEG Interferon lambda 60 Phase IIb clinical 60 tolerated dose MTD 60 randomized Phase III 60 Phase IIa trial 60 dose escalation study 60 tezampanel 60 Phase 2b study 60 Debio 60 HGS ETR1 60 muraglitazar 60 PS# [001] 60 single ascending dose 60 rHuPH# 60 phase IIb 60 noninferiority 60 pharmacokinetic 60 randomized controlled clinical trials 60 pharmacodynamics 60 Alpharadin 59 integrase inhibitor 59 Ostarine 59 IIa clinical trial 59 radiolabeled 59 PF # [001] 59 tesmilifene 59 HuMax CD# 59 Zerenex 59 dose cohorts 59 dose limiting toxicities 59 ozarelix 59 Chrysalin 59 AVE# 59 Phase 2a 59 INCB# [002] 59 eltrombopag 59 alvimopan 59 safety tolerability pharmacokinetics 59 CA4P 59 FOSRENOL R 59 pharmacokinetics 59 nitazoxanide 58 Androxal 58 nab paclitaxel 58 transcriptase inhibitor NNRTI 58 AFRESA 58 Phase IIa 58 immunogenicity 58 Phase 2b trial 58 BMS # 58 ANAVEX #-# [003] 58 placebo controlled studies